SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (579)4/2/1997 8:32:00 PM
From: margie   of 6136
 
Here are the analysts who cover Agouron, some are pretty well known. I am sure they cover other biotechs too.

Analyst Coverage.

Anthony Butler, Ph.D., Lehman Brothers
David Crossen, Ph.D., Montgomery Securities
Edward Hurwitz, Robertson Stephens & Co.
Robert LeBoyer, Brown Bros. Harrimen
Douglas Lind, M.D., PaineWebber
David Molowa, Ph.D., Bear Stearns
Kevin Tang, Alex Brown & Sons

Douglas Lind, M.D., is with Morgan Stanley now. Remember when the stock tanked when he left Paine Webber, co-incidentally several days before FDA approval of Viracept. The fear was that Lind would not cover the stock anymore. It didn't take long for Lind to give a strong buy from Morgan Stanley.
Alicia Wang (sp?) is the analyst at Paine Weber now.

Great home page for Agouron.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext